font size
printPrint


Law

Subtopics:

PATENTS:

Thinking Small

U.S. patent officials and other regulators must get up to speed on the intricacies of tiny particles to avoid hindering the growth of nanotechnology.


As the gold rush of nanotechnology converges with biotech to form a biomolecular economy, the very shape-shifting, boundary-crossing nature of this field that holds such promise also makes it a regulator’s nightmare. Already, the U.S. Food and Drug Administration (FDA) and the U.S. Patent and Trademark Office (USPTO) are being criticized for their approaches as they attempt both to encourage and to impose order on the field. 

READ MORE.

 

  • Untethering Innovation    
    One year before a new president takes office, Congress lies low, but bills on patents, biologics, genetics, and a host of other issues could still affect R&D.
    February 11, 2008 - BRADFORD PLUMER - Law - Legislation
  • Medicare Needs to Get with the Times
    Outdated reimbursement policies for state-of-the-art diagnostics tools are hindering innovation.
    January 03, 2008 - TERESA LEE - Law - Legislation
  • Scientists Rewrite Murder Mystery
    DNA evidence raises new questions about a nearly 100-year-old conviction.
    December 27, 2007 - ERIC WAHLGREN - Law - Crime
  • Stem Cells vs. Jail Cells    
    German researchers face down Draconian rules.
    November 01, 2007 - MARY LISBETH D'AMICO - Law - Patents
  • A Booby Prize
    Scrapping the patent system for drugs for a reward model is a bad idea
    October 23, 2007 - PETER J. PITTS - Law - Patents
  • A Thorn in Pharma's Side
    Patent watchdog Dan Ravicher touts the need for patent reform after getting the U.S. government to review Gilead's patents for its leading HIV drug.
    July 18, 2007 - DANIEL S. LEVINE - Law - Patents
  • Key Patent Ruling No Biotech Killer
    U.S. Supreme Court refines what "obvious" means for patents, but doesn't scrap protection for innovators.
    May 16, 2007 - COURTENAY C. BRINCKERHOFF - Law - Patents
  • Eye on the Street
    The latest news and numbers from Wall Street.
    January 22, 2008 - Business - Markets
  • Eye on the Street
    The latest news and numbers from Wall Street.
    January 22, 2008 - Business - Markets
  • Simple Math
    Pharma should partner with industry in developing nations to create cost-scaled markets within the world's emerging economies.
    July 21, 2007 - LISA CONTE - Health - Global Health